title: Validation and application of reporter gene assays for the determination of estrogenic and androgenic endocrine disruptor activity in sport supplements.
abstract: Previously developed estrogen and androgen mammalian reporter gene assays (RGAs) were assessed for their potential use as a quantitative screening method in the detection of estrogenic and androgenic endocrine disruptors (EDs) in sport supplements. The validation of both RGAs coupled with dispersive solid phase extraction (dSPE) was performed in accordance with European Commission Decision EC/2002/6579 for biological screening methods. Decision limits (CCα) and detection capabilities (CCβ) were established for both the estrogen and androgen RGAs. All samples were compliant with CCα and CCβ in both bioassays. Recovery rates were 96 % for 17β-estradiol and 115 % for dihydrotestosterone as obtained in their corresponding RGA. Both estrogens and androgens were stable in samples for more than 3 weeks, when stored at -20 °C. Specificity, good repeatability (coefficients of variation (CV), 12-25 %), reproducibility and robustness of both bioassays were also observed. Four different ED modes of action were determined for estrogens and androgens in 53 sport supplements, using the validated RGAs. This study revealed that 89 % of the investigated sport supplements contained estrogenic EDs and 51 % contained androgenic compounds. In conclusion, both bioassays are suitable for sport supplement screening of estrogenic and androgenic EDs.
authors.affiliation: Institute of Agri-Food and Land Use, School of Biological Sciences, Queen's University Belfast, Northern Ireland, UK.
authors.forename: Monika
authors.initials: M
authors.lastname: Plotan
authors.forename: Christopher T
authors.initials: CT
authors.lastname: Elliott
authors.forename: Michalina
authors.initials: M
authors.lastname: Oplatowska
authors.forename: Lisa
authors.initials: L
authors.lastname: Connolly
mesh_terms: D000728:Androgens / Q000032:analysis* / Q000494:pharmacology*; D000818:Animals; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D019587:Dietary Supplements / Q000032:analysis*; D052244:Endocrine Disruptors / Q000032:analysis* / Q000494:pharmacology*; D017930:Genes, Reporter; D052616:Solid Phase Extraction; D013177:Sports; D013329:Structure-Activity Relationship
chemical_list: D000728:Androgens; D052244:Endocrine Disruptors